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Chromosomal instability (CIN) in tumors is characterized by chromosomal abnormalities and an altered gene
expression signature; however, the mechanism of CIN is poorly understood. CCND1 (which encodes cyclin D1)
is overexpressed in human malignancies and has been shown to play a direct role in transcriptional regulation.
Here, we used genome-wide ChIP sequencing and found that the DNA-bound form of cyclin D1 occupied the
regulatory region of genes governing chromosomal integrity and mitochondrial biogenesis. Adding cyclin D1
back to Ccnd1–/– mouse embryonic fibroblasts resulted in CIN gene regulatory region occupancy by the DNAbound form of cyclin D1 and induction of CIN gene expression. Furthermore, increased chromosomal aberrations, aneuploidy, and centrosome abnormalities were observed in the cyclin D1–rescued cells by spectral
karyotyping and immunofluorescence. To assess cyclin D1 effects in vivo, we generated transgenic mice with
acute and continuous mammary gland–targeted cyclin D1 expression. These transgenic mice presented with
increased tumor prevalence and signature CIN gene profiles. Additionally, interrogation of gene expression
from 2,254 human breast tumors revealed that cyclin D1 expression correlated with CIN in luminal B breast
cancer. These data suggest that cyclin D1 contributes to CIN and tumorigenesis by directly regulating a transcriptional program that governs chromosomal stability.
Introduction
Chromosomal instability (CIN) in tumors (1–3) is characterized
by an elevated rate of gain or loss of whole chromosomes (i.e.,
aneuploidy) and/or as structural chromosomal aberrations (i.e.,
translocations, deletions, and duplications). Aneuploidy is one of
the most striking differences between cancer and normal cells.
The molecular mechanisms inducing CIN as well as the timing
of CIN in tumor progression, invasion, and metastasis is poorly
understood (4, 5). Cell cycle–associated factors have been implicated in CIN, including cyclin E (6). The relative enrichment of a
molecular genetic signature of CIN-related genes has been used to
quantitate a CIN score (7); this signature includes AURKB (a component of the chromosomal passenger complex [CPC]), TOP2A,
CENPP, MLF1IP (a component of the CENPA-NAC kinetochore
complex protein), ZW10 (a kinetochore-associated mitotic checkpoint protein), and CKAP2 (a mitotic spindle-associated protein)
(3) as well as the retinoblastoma (pRb) protein. Supernumerary
centrosomes increase the frequency of dual attachment of 1 sister
kinetochore to 2 spindle poles. Cyclin E activity promotes centrosome duplication during S phase onset. Loss of pRb can also alter
centrosome number and formation of micronuclei, leading to
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mis-segregation of chromosomes and aneuploidy (8). CIN occurs
relatively early in tumor progression, whereas pRb loss occurs
relatively late in the process of tumorigenesis, which raises the
question of candidate mechanisms driving chromosomal aberrations in the early phase of tumor onset.
Cyclin D1 (CCND1) encodes the regulatory subunit of the holoenzyme that phosphorylates and inactivates pRb and the NRF1
proteins to regulate nuclear DNA synthesis and mitochondrial
biogenesis (9–13). Quantitative single-cell analysis has shown that
cyclin D1 levels oscillate during the cell cycle, increasing in a broad
array of cell types during the G2 phase (14). Cyclin D1 expression is
increased 3- to 8-fold in human breast, prostate, lung, and gastrointestinal malignancies (15–18). Furthermore, the cyclin D1 oncogene directly induces mammary gland tumors in mice (19). Cyclin
D1 is required for oncogene-dependent growth, as genetic ablation
of murine Ccnd1 impaired terminal alveolar breast bud development (20) and resulted in resistance to Ras- or ErbB2-induced
mammary tumorigenesis and to APC-induced gastrointestinal
tumorigenesis (21, 22). Over the last 2 decades, a substantial body
of evidence has suggested cyclin D1 plays a direct role in transcriptional regulation (16). Cyclin D1 physically associates with, and
regulates the transcriptional activity of, ERα (23) and more than 30
other transcription factors (TFs) (16). The histone acetyltransferases p300, p300/CREB-binding protein–associated factor (P/CAF),
and AlB1 bind to cyclin D1 (24, 25). ChIP demonstrated cyclin D1
association within the local chromatin of target gene promoters
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that correlated with deacetylation of histone (H3), in particular at
H3 lysine 9 (H3lys9). Deacetylation of H3lys9 was restored upon
reintroduction of cyclin D1, which recruited HDAC1/HDAC3 (17,
22). Thus, cyclin D1 is recruited in the context of local chromatin
to specific target genes (26, 27). Cyclin D1 recruitment to local
chromatin was also associated with recruitment of p300 to regulate genes governing DNA damage repair signaling (26). Cyclin D1
was shown to regulate the activity of p300 independently of cyclindependent kinase (CDK) binding function. As p300 is regarded as
a transcriptional cointegrator, cyclin D1 was proposed as a regulator of gene transcription through co-occupancy with p300 at target DNA-binding sites (26).
Recent studies demonstrated the occupancy of cyclin D1 in the
context of local chromatin using ChIP-ChIP analysis on a –5.5 kb
to +2.5 kb ChIP-ChIP microarray containing approximately 17,000
genes (28). In addition, cyclin D1 associated with the p300-related
CREB-binding protein (CBP) in a proteomics screen and recruited
CBP to the Notch1 gene to regulate its transcription. Here, we aimed
to expand the interrogation of cyclin D1 TF binding sites to the
entire genome and to include potential cyclin D1 interactions
both within and outside the proximal 8 kb of a gene’s start site. We
therefore performed ChIP of cyclin D1 followed by ChIP sequencing (ChIP-Seq) to map at high resolution the entire genomic region
bound by cyclin D1. Functional pathway analysis of the gene regulatory elements bound by cyclin D1 uncovered enrichment for genes
that govern chromosomal stability. Our data suggest that cyclin
D1 contributes to CIN and tumorigenesis by directly regulating a
transcriptional program that governs chromosomal stability.
Results
Defining genome-wide cyclin D1 binding sites. In view of our prior
findings that cyclin D1 occupies promoter regulatory regions in
the context of local chromatin associated with the recruitment of
p300 (17, 26, 29), we conducted genome-wide analysis of cyclin
D1 genomic occupancy using ChIP-Seq analysis. In order to characterize genome-wide cyclin D1 binding sites, Ccnd1–/– mouse
embryonic fibroblasts (MEFs) were transduced with a FLAG
epitope–tagged expression vector encoding cyclin D1 (30). The
exogenous levels of cyclin D1 in rescued cells were approximately
3-fold higher than basal levels (Supplemental Figure 1A; supplemental material available online with this article; doi:10.1172/
JCI60256DS1), consistent with the 3- to 8-fold increase in cyclin
D1 levels observed in breast and other tumor types (18, 31). In
order to characterize genome-wide cyclin D1 DNA binding sites
in vivo, ChIP-Seq was conducted using Genpathway’s FactorPath
discovery technology. We found 2,840 NCBI genes with intervals
within 10 kb of the start site. A summary of the active regions
and their proximity to NCBI-designated genes is given in Supplemental Table 1. Figure 1A shows the genome-wide distribution
of 2,840 binding sites in relation to the transcriptional start site.
Interestingly, peak values of active regions within the promoter
were comparable to those 10 kb and beyond (Figure 1B), which
suggests that cyclin D1 localizes to both promoter-proximal elements and very distant elements. Analysis of the tag density distribution at the promoter-proximal region identified the enrichment of cyclin D1 occupancy within approximately 500 bp of the
transcriptional start site (Supplemental Figure 1, B and C).
In order to determine the TF binding sites enriched in the cyclin
D1 peak interval sequences, we used the JASPAR Match server (32),
employing a permutation test. Only those intervals within 2 kb of
834
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the transcription start site were processed. Figure 1C shows DNA
recognition sequences and statistical significance for the top hit
TFs Ctcf (a zinc finger protein; also known as CCCTC-binding factor), Zfx (a member of the krueppel C2H2-type zinc finger protein
family), Sp1 (a TF belonging to the Sp/KLF family), Mizf (a zinc
finger protein that has a key role in histone gene expression; also
known as Hinfp), estrogen receptor R1 (Esr1; also known as ERα),
E2f1 (a member of the E2F family that transcriptionally activates
numerous genes involved in cell cycle regulation), Creb1 (a cAMP
element–binding protein activated by cAMP usually through hormonal stimulation), and Hif1α/Arnt (which regulates key genes
involved in hypoxic stress). A full list of TFs and their statistical
significance is provided in Supplemental Table 2. The prevalence
of TF motifs in the interval sequence was plotted for the top 20
TFs (Supplemental Figure 1D). We next asked whether a consensus sequence was present in the peak interval regions. We used
the complete 3,222-peak interval data set and split the data into
4 groups based on proximity to nearest neighbor transcriptional
start sites. In 3 of the groups, the motif was an exact copy of the
CTCF invariant core sequence (Supplemental Figure 1E). We used
luciferase reporter constructs containing multimeric copies of the
consensus sequence alone to verify that cyclin D1 regulated the
transcriptional activity of several members of the TF list (i.e., Myc,
E2F, and Hif1α; Supplemental Figure 2). These data are consistent with a model in which cyclin D1 is recruited in the context of
local chromatin to regulate gene transcription and occupies DNA
elements that associate with TFs.
Cyclin D1 binds genes that regulate chromosomal stability. An unbiased
determination of the functional pathways using the annotation
clustering feature of NIH Database for Annotation, Visualization,
and Integrated Discovery (DAVID) demonstrated that cyclin D1
bound the regulatory region of the genes involved in RNA processing, mitochondrial function, and DNA organization and segregation (Figure 2A). Previous work by Bienvenu et al., using a ChIP
promoter array that examined approximately 1% of the genome,
demonstrated that cyclin D1 associates with approximately 900
genes in close proximity to the transcriptional start site (P < 1 × 10–4;
ref. 26). Extension through ChIP-Seq to interrogate the additional
components of the entire genome revealed considerable functional
overlap, with additional functions identified through the global
genomic analysis (Supplemental Figure 3).
Based on the functional annotation analysis, there were a large
number of gene sets associated with cell division. We analyzed these
sets further to extract the associated genes; a list of the genes associated with the Gene Ontology (GO) term cell division is provided
in Supplemental Table 3. Most of the genes were involved in G2/M
phase and cellular mitosis. Given the high number of genes that
regulate mitosis, we determined whether the genomic regions that
associate with cyclin D1 correlate with a CIN function. When genes
were ranked based on CIN score (7), those regulatory regions occupied by cyclin D1 were significantly enriched (P < 0.0001; Figure 2B).
Most of the mitotic genes are involved in chromatin reorganization and chromosomal segregation during M phase. Representative tag density profiles for several members of the list are
depicted in Figure 2C. The relative abundance of transcripts
coding for proteins that regulate chromosomal segregation were
increased around 1.5- to 2-fold by cyclin D1 expression, including
Aurkb, Ckap2, Mlf1ip, and Zw10 (Figure 2D). We also performed
quantitative RT-PCR on 2 other GO terms: protein catabolic process
and RNA processing. The expression of the genes representative of
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Figure 1
Identification of cyclin D1–bound sequences. (A) Distribution of the 2,840 intervals with respect to neighboring genes. Intervals were categorized
as being upstream of transcriptional start site (TSS), in gene and downstream of TSS, or downstream of the gene. Because some intervals had
more than 1 associated gene, some were associated with more than 1 term. Upstream of TSS was defined as –10,000 to 0 bp. (B) Peak values
in the anti-FLAG/CCND1 ChIP-Seq compared with IgG control. The peak values within promoter regions were similar to those 10 kb from the
transcriptional start site. ActRegs, active regions. Bounds of the boxes denote SD; lines within boxes denote mean; whiskers denote interquartile
range; symbols denote outliers. (C) Select example of conserved TF motifs enriched within the interval regions associated with cyclin D1. See
Supplemental Table 2 for the full list of TFs.

those terms was also regulated by cyclin D1 (Supplemental Figure
4A). In addition, we verified by Western blot analysis that Aurkb,
a key regulator of the mitotic checkpoint control, was increased
in abundance by cyclin D1 (Supplemental Figure 4B). Cyclin D1
increased phosphorylation of H3S10, a target of Aurkb (33, 34).
AURKB is overexpressed in human malignancies like prostate,
colorectal, kidney, lung, and breast cancers (35), and its overexpression results in multinucleation and polyploidy in human
cells. ChIP analysis using relevant and negative control primer sets
(Figure 2E and Supplemental Figure 4C) confirmed the ChIP-Seq
data, indicative of occupancy by cyclin D1 at the promoter regions
of genes involved in regulation of chromosome segregation (i.e.,
Aurkb, Top2a, Cenpp, Mlf1ip, Zw10, and Ckap2). These results suggest that cyclin D1 contributes to CIN by transcriptional regulation of genes involved in mitosis.
Cyclin D1 promotes CIN. The cyclin D1–dependent enrichment of
genes involved in chromosomal segregation and stability led us to
The Journal of Clinical Investigation

determine the functional consequence using a cyclin D1 expression profile, fluorescence-activated cell sorting (FACS) analysis,
and spectral karyotyping (SKY). We first used a previously published cyclin D1 expression profile to determine enrichment for
the CIN profile. Induction of cyclin D1 expression in MEFs using
a cyclin D1 retrovirus induced expression of CIN-associated genes
(P < 0.0001; Figure 3A). We next assessed the effect of cyclin D1
on ploidy by reintroducing cyclin D1 into Ccnd1–/– cells (a process
referred to herein as cyclin D1 rescue). The proportion of polyploid
cells increased within 3 cellular divisions, increasing the relative
proportion of 4N and 8N cells by 45% and 15%, respectively (Figure 3, B and C). Using SKY, we analyzed 20 metaphase spreads of
cyclin D1–rescued versus control Ccnd1–/– cells (Figure 3, D and E,
and Supplemental Figure 5, A and B). Graphical representation
of the karyotype analysis of all 20 metaphases is shown in Figure
3F. Since mouse fibroblasts are prone to genomic instability when
successively passaged in culture, a deviation of ±2 chromosomes
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Figure 2
Cyclin D1 associates with genes involved in mitosis. (A) Functional annotation clustering by DAVID of cyclin D1–associated genes, based on
percent enrichment score of the top hits. (B) Cyclin D1–bound promoter regions (0 to –500 bp) were enriched in genes demonstrating an association with CIN (P < 0.0001). (C) Representative tag density profiles of cyclin D1–bound regions and their proximity to the transcriptional start site
(arrow). Peak values for the intervals are denoted by asterisks. (D) Quantitative PCR on target mRNAs selected based on cyclin D1–associated
genes. Shown are normalized expression ratios of Ccnd1–/– cells with MSCV-FLAG/CCND1 compared with MSCV-control (n = 4 separate cell
lines; data are mean ± SEM). (E) ChIP analysis of Ccnd1–/– 3T3 cells transduced with MSCV-FLAG/CCND1 using anti-FLAG antibody. Primers
were designed against the peak interval sequence.

at 2N and 4N is considered normal. By this criterion, 75% of the
Ccnd1–/– MEF metaphases had a normal karyotype compared with
30% of the cyclin D1–rescued Ccnd1–/– MEFs (P < 0.001). Just as
pronounced as the aneuploidy was the number of chromosomal aberrations observed in the cyclin D1–rescued Ccnd1–/– line.
Defects identified by SKY are assigned as deletions, duplications,
and translocations. There were significantly more translocations
in the cyclin D1–rescued compared with control Ccnd1–/– MEFs
(Figure 3G), although no significant differences in deletions and
duplications were identified (Supplemental Figure 6, A and B).
Most prevalent were the nonreciprocal translocations (NRTs) and
reciprocal translocations, the latter of which was present in 7 of 20
836
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metaphases analyzed. NRTs predominate in human carcinomas,
as characterized by karyotype analysis, and contribute to carcinogenesis by carrying oncogenes at their breakpoints and also by
distorting normal gene dosage (36). The number of NRTs in the
cyclin D1–rescued line was 13 events, compared with 3 in the control. A full list of rearrangements is given in Supplemental Table 4.
We also conducted SKY analysis of 3T3 control and cyclin D1–rescued Ccnd1–/– cells at passage 23 (P23) to determine whether the
abnormal karyotype was present in late-passage cells (Figure 3, H
and I, and Supplemental Figure 5, C and D). Although control
Ccnd1–/– cells exhibited significantly higher polyploidy than did
low-passage Ccnd1–/– MEFs, the rates were higher in cyclin D1–res-

http://www.jci.org

Volume 122

Number 3

March 2012

research article

Figure 3
Cyclin D1 rescue of Ccnd1–/– MEFs induces polyploidy and aneuploidy. (A) The expression profile for cyclin D1–induced genes (63) was
enriched for high CIN score (P < 0.0001). (B) PI staining demonstrated increased polyploidy in cyclin D1–rescued versus control Ccnd1–/– MEFs.
(C) Quantitation of PI staining based on 3 separate cell lines (mean ± SEM). *P < 0.005. (D, E, H, and I) Representative metaphases from SKY
of control and cyclin D1–rescued Ccnd1–/– MEFs at P6 (D and E) and 3T3 cells at P23 (H and I). Shown for each is an inverted DAPI image of
the metaphase (top right), a raw spectral image of the metaphase (top left), and classification of the same metaphase (bottom). (F and J) Chromosomal number across metaphase spreads from control and cyclin D1–rescued Ccnd1–/– MEFs at P6 (F) and 3T3 cells at P23 (J), showing
the total number of chromosomes for 20 mitotic spreads. Gray shading represents expected deviation from normal at 2N and 4N (± 2 chromosomes). P < 0.001, rescue vs. control, χ2 test of association. (G and K) Reciprocal translocations and NRTs in metaphase spreads from control
and cyclin D1–rescued Ccnd1–/– MEFs at P6 (G) and 3T3 cells at P23 (K), shown as number of events per cell analyzed. The mean distribution
is represented as a red curve.

cued Ccnd1–/– cells (P = 0.05; Figure 3J). In addition, there were substantially more reciprocal translocations and NRTs (Figure 3K),
with little difference in deletions and duplication events between
the 2 lines (Supplemental Figure 6, C and D). Taken together,
these data suggest that acute rescue of Ccnd1–/– MEFs induces CIN
with a high NRT rate.
Multipolar spindles and centrosome amplification predominate in
cyclin D1–rescued Ccnd1–/– cells. In order to screen for potential
abnormalities in mitosis that could contribute to CIN, we performed immunofluorescence followed by high-resolution confoThe Journal of Clinical Investigation

cal imaging on 3T3 control and cyclin D1–rescued Ccnd1–/– cells
using markers of mitotic spindles and centrosomes (α- and
γ-tubulin, respectively). The number of cells with multipolar
spindles increased 27% in cyclin D1–rescued relative to control
Ccnd1–/– cells (P = 0.0289; Figure 4, A and B). Because multipolar spindles arise from abnormalities in centrosome number and
distribution, we stained cells for γ-tubulin in conjunction with
α-tubulin to quantitate the number of centrosomes. The percentage of prometaphase/metaphase cells with more than 2 centrosomes increased 19% in cyclin D1–rescued compared with control
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Figure 4
Cyclin D1 induces centrosome amplification and mitotic spindle disorganization. (A and C) Representative confocal maximum Z projections of
mitotic cells (A; immunostained for α-tubulin [violet] and DAPI [blue]) and prophase, prometaphase, and metaphases (C; immunostained for
α-tubulin [violet], γ-tubulin [yellow], and DAPI [blue and insets]) from control and cyclin D1–rescued Ccnd1–/– cells. Original magnification, ×60
NA1.4 oil objective, enlarged ×5 by digital zoom. Scale bars: 5 μm. (B and D) Frequency of mitotic cells with multiple polar spindles (B) and of
prometaphase/metaphase cells with multiple centrosomes (γ-tubulin) and spindle disorganization (α-tubulin) (D). *P = 0.0289, χ2 analysis. Black
bar, abnormal centrosome count (i.e., >2); gray bar, normal count (i.e., 2). (E and F) Spindle measurements on maximum Z projections of metaphase control and cyclin D1–rescued Ccnd1–/– cells. Data are mean ± SEM. Insets demonstrate metaphase plate (i.e., chromatin; Ch) width and
length (measured using DAPI stain) and spindle (Sp) width and length (measured using tubulin stain). *P = 0.0486; **P = 0.0087.
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Figure 5
Heat maps displaying genes differentially regulated by cyclin D1 in
transgenic mouse models. (A) Genes differentially regulated between
rtTA/CCND1 tumors (n = 3) and normal mouse mammary glands from
rtTA control mice (n = 2), visualized by hierarchical clustering. (B) The
most highly differentially regulated genes (Fold>2, B>3) were enriched
for CIN in the rtTA/CCND1 profile (P < 0.0001). (C) Genes differentially
regulated between MMTV-CCND1–induced tumors (n = 3) and normal
mouse mammary glands (n = 2), visualized by hierarchical clustering.
(D) The most highly differentially regulated genes (Fold>2, B>4) were
enriched for CIN in the MMTV-CCND1 profile (P < 0.0001).

Ccnd1–/– cells (P = 0.0289; Figure 4, C and D). Spindle architecture
was clearly abnormal in cyclin D1–rescued Ccnd1–/– cells, resulting in multipolar spindles that perpetuated from prophase to
prometaphase and failed to coalesce at metaphase (Figure 4D).
The alteration of spindle architecture was associated with the
disruption of metaphase plate morphology, detected with DAPI
staining (Figure 4E). Width and length of metaphase plates and
spindles were measured in the same samples; consistent with the
increase in spindle and centrosome abnormalities, plate width
and spindle length were significantly increased in cyclin D1–rescued Ccnd1–/– cells (P = 0.0087 and P = 0.0486, respectively; Figure
4, E and F). Lagging chromosomes, anaphase bridges, and micronuclei were also observed in cyclin D1–rescued compared with
control Ccnd1–/– cells (Supplemental Figure 7). These results demonstrated increased prevalence of centrosome amplification that
contributed to mitotic spindle abnormalities.
Cyclin D1 promotes CIN expression profiles in vivo. In order to directly
assess the role of cyclin D1 in promoting CIN, we developed transThe Journal of Clinical Investigation

genic mouse mammary models to either acutely express cyclin D1
in the mammary gland using the tetracycline-inducible system
or an MMTV-cyclin D1 system. For the tet-inducible transgenic
mice (reverse tetracycline-controlled transactivator cross-mated
with CCND1 transgenic [rtTA/CCND1]; Supplemental Figure 8A),
RT-PCR analysis and Western blotting demonstrated that cyclin
D1 expression levels were induced via tetracycline (Supplemental
Figure 8, B and C). To examine the expression profiles induced by
cyclin D1 in the mammary gland, we treated mice with tetracycline for 7 days, then performed microarray analysis to compare
the cyclin D1 transgenic mice with rtTA-positive control mice that
had undergone the same tetracycline regimen (Figure 5A). We then
compared the genes that were most differentially regulated in the
2 sets (i.e., Fold>4 and log odds ratio of differential gene expression greater than 3 [B>3]) with the CIN signature gene set and
found that the rtTA/CCDN1 gene profile was enriched for CIN
(P < 0.001; Figure 5B). The MMTV-cyclin D1 transgenics (Supplemental Figure 8D) were confirmed by Northern blotting and
Western blotting for FLAG-tagged cyclin D1 (Supplemental Figure
8E). Female MMTV-CCND1 and WT mice were monitored twice
weekly for the development of palpable tumors. Those developing
palpable tumors were sacrificed within a week of tumor detection.
Kaplan-Meier survival and tumor-onset plots, and analyses with
a log-rank test for curve comparisons, were performed between
MMTV-CCND1 and WT lines (Supplemental Figure 8F). The first
instances of tumor onset occurred at around 400 days in MMTVCCND1 mice, whereas WT mice were tumor free at this age. At 760
days, the tumor-free fraction in the MMTV-CCND1 group was 42%
compared with 85% in the WT group (P = 0.0018). The relative
abundance of cyclin D1 was also assessed in normal mammary epithelial cells and found to be concordant with the increased level of
cyclin D1 present in human breast cancer samples (Supplemental
Figure 8G and ref. 31).
To determine the genes that are regulated by MMTV-CCND1,
microarray analysis was performed on tumors obtained from agematched mice and compared with mammary glands of WT (FVB)
mice (Figure 5C). We then compared the genes that were most differentially regulated in the 2 sets (i.e., Fold>4 and B>3) with the
CIN signature gene set and found the MMTV-CCND1 gene profile
to be enriched for CIN (P < 0.0001; Figure 5D). Taken together,
these data suggest that cyclin D1 induces enrichment of CIN score
upon acute induction or with constitutive long-term expression in
the mammary epithelium of mice.
High cyclin D1 expression correlates with CIN in luminal B breast cancer subtype. To analyze the association between CIN and cyclin
D1 expression in the context of breast cancer, we aligned the
expression of a 70-gene set with the highest CIN score against a
collection of 2,254 breast cancer samples compiled from public
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Figure 6
Subtype classification of breast cancer microarray samples. (A) Heatmap depicting samples from combined breast cancer microarray datasets
that were assigned to the 5 breast cancer gene expression subtypes. The predicted ESR1, epidermal growth factor receptor (ERBB2), and
progesterone receptor (PGR) statuses are shown together with CIN signature score and CCND1 expression level across the 5 subtypes. The
luminal B subtype receptor status, CIN signature score, and cyclin D1 expression level is outlined. (B) CCND1 transcript level plotted versus
average CIN signature expression level revealed that the relationship between high CIN score and high cyclin D1 expression was luminal B
subtype specific (red circle). (C) Kaplan-Meier plot showing differences in metastasis-free status in this dataset (P = 6.4462 × 10–8).
840
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microarray databases (37). We stratified the samples based on previously described breast cancer subtypes (38) and aligned them
with the cyclin D1 expression profile across the dataset. A significant correlation among cyclin D1, CIN, and the luminal B subtype
was identified (P < 1 × 10–10; Figure 6A). Scatter plots depicting
CCND1 transcript level versus average CIN signature expression
level revealed that the relationship between these expression levels
was breast tumor subtype specific (Figure 6B). Kaplan-Meier plots
showed differences in metastasis-free survival in this dataset (Figure 6C). We conclude that individuals with luminal B type breast
cancer have elevated CIN expression profiles that correlate with
high cyclin D1 expression.
Discussion
Our present findings indicate that cyclin D1 induces CIN. Cyclin
D1 induced gene expression profiles characteristic of CIN in fibroblasts, in the mammary gland, and in cyclin D1–induced mammary tumors. Transient expression of cyclin D1 over 7 days in the
mammary gland was sufficient to induce CIN gene expression.
SKY analysis confirmed the induction of aneuploidy and polyploidy by cyclin D1 expression in Ccnd1–/– MEFs. Immunofluorescence
demonstrated the occurrence of supernumerary centrosomes that
formed multipolar spindles. A careful analysis of the relative abundance of the genes involved in CIN identified a cluster of genes
regulating the G2/M checkpoint and mitosis. The relative abundance of these genes was increased by cyclin D1 expression, as confirmed by quantitative PCR. The finding that cyclin D1 induced
CIN is of importance, as CIN is an early feature of tumorigenesis
that may precede tumor suppressor loss (39, 40). Previous studies
showed that cyclin E, but not cyclin D1, is capable of inducing
CIN (6). However, cyclin D1 overexpression correlated with aneuploidy, supernumerary centrosomes, and spindle defects in mouse
hepatocytes (41) and with aneuploidy and polyploidy in lymphoid
tumors (42). In addition, cyclin D1 amplification correlated with
centrosome amplification in bladder cancer (43). As cyclin D1
expression is increased in the early phases of tumorigenesis, cyclin
D1 may be an important inducer of CIN in tumors.
Analysis of clinical samples with molecular genetic subtyping
identified the correlation of the CIN signature with cyclin D1
overexpression and luminal subtype B breast cancer. The presence of CIN in this genetic subtype correlated with poor outcome.
Previous studies examining the role of cyclin D1 in outcome have
provided contradictory results, with some suggesting a positive
correlation between cyclin D1 expression and outcome and others showing reduced survival (16, 44, 45). Cyclin D1 levels were
induced in luminal A and B subtypes, but correlated with CIN in
luminal subtype B. CIN is usually poorly tolerated by cells initiating cell death signaling. As luminal A and luminal B breast cancer subtypes have distinct molecular genetic profiles, there may
be additional genetic changes in the luminal B tumors that allow
the survival of cells with genomic instability. It may well be that
the genetic subclassification, as conducted in the current studies,
is important in determining the clinical significance of cyclin D1
overexpression. The recent identification of drugs targeting CIN
(46, 47) may provide a rational basis for therapeutic substratification, supplementing with compounds targeting CIN in the luminal B subtype of breast cancer.
Here, we conducted a genome-wide analysis of cyclin D1 binding
in the context of local chromatin using ChIP-Seq analysis. Our
prior studies demonstrated the recruitment of cyclin D1 in the
The Journal of Clinical Investigation

context of local chromatin to TF binding sites, which was associated with recruitment of SUV39H1 and HP1α and commensurate
reduced acetylation and increased trimethylation of H3lys9 (17,
26). Subsequent studies by ChIP-ChIP covering –5.5 to +2.5 kb of
a subset of promoters similarly identified cyclin D1 recruitment to
a subset of target genes involved primarily in notch signaling and
cellular proliferation (28).
How might cyclin D1 regulate gene expression in the context of
local chromatin? Although intrinsic DNA sequence–specific binding of cyclin D1 has not been identified, cyclin D1 has been identified at sites of damaged DNA in the context of local chromatin
(48, 49). Various TFs associate with cyclin D1 in IP–Western blot
analysis, and the abundance of cyclin D1 can regulate the recruitment of TFs (22) and transcriptional coregulators (26, 29) in the
context of local chromatin in ChIP assays. Given these findings, we
had proposed that cyclin D1 is recruited either to DNA through
sequence-specific binding proteins to regulate gene expression
or to damaged DNA via Rad51 and the related repair complex,
which thereby recruits BRCA proteins (29, 48). Cyclin D1 abundance determines the recruitment of cointegrator and chromatin
remodeling proteins in ChIP assays, including p300/CBP (26,
29), SUV39H1, HP1α, and HDAC1/3 (17), and dictates acetylation and dimethylation of local histones (e.g., H3 and H4). The
mechanisms permitting assembly of the cointegrator regulatory
complex that are associated with cyclin D1 at a given cis element
remain to be determined. Prior studies using cyclin D1 and p300
knockout mice showed that, in the case of genes governing the
fidelity of DNA replication (e.g., MCM3, MCM4, and RfCH), their
abundance was induced by cyclin D1 and reciprocally regulated
by p300, consistent with previous findings that cyclin D1 inhibits p300 autoacetylation (26). Although the regulation of TFs and
cointegrator activity was independent of the cdk-binding domain,
the role of the cyclin D1 cdk-binding domain in regulating the
CIN signature in vivo remains to be determined.
The current studies identified a distinct subset of cis elements
occupied by cyclin D1, due in part to the distinct interrogation of
the genome conducted herein. The current studies examined both
noncoding and coding DNA and sites distal to the transcription
start site and identified a proclivity for cyclin D1 to occupy the
CTCF binding factor site. CTCF functions in chromatin reorganization and as an enhancer insulator (50). It is of interest that the
cohesin complex — important in segregation of sister chromatids,
which were altered in a cyclin D1–dependent manner — interacts
with CTCF. The cohesin complexes are also found at a large fraction of CTCF sites in vivo (51, 52). Because CTCF is a chromatin reorganizer and has the potential to play a bidirectional role
through the cohesin complex, it will be of interest to determine
the relative importance of cyclin D1 in regulating CTCF-dependent global transcription.
Methods
Further information can be found in Supplemental Methods.
Cell culture, cell lines, and transgenic mice. The MSCV-IRES-GFP retroviral
vector and cyclin D1 WT constructs were previously described (53). Ccnd1+/+
and Ccnd1−/− primary MEF cultures were prepared as described previously
(54). Cells were maintained in DMEM supplemented with 10% fetal bovine
serum and 100 μg/ml each of penicillin and streptomycin.
Retrovirus production and infection. Retroviral production and infection of
Ccnd1−/− MEFs were described in detail previously (53). FACS-sorted (FACStar
Plus; BD Biosciences) GFP+ cells were used for subsequent analysis.
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ChIP-Seq analysis and TF enrichment. Genpathway’s FactorPath method
was carried out as previously described by Labhart et. al (55). Gene libraries were sequenced using Genome Analyzer II and aligned to the mouse
genome using Eland (Illumina). TF enrichment in ChIP-Seq intervals was
conducted using the Jasper server.
Western blotting and luciferase assays. Whole cell lysates or homogenized
tissue lysates (50 μg) were subjected to Western blotting as previously
described (56). The following antibodies were used for Western blotting:
guanine nucleotide dissociation inhibitor (GDI; ref. 57), cyclin D1 (catalog
no. MS-210-P; NeoMarkers), FLAG-tagged M2 (catalog no. F1804; SigmaAldrich), β-tubulin (catalog no. T4026; Sigma-Aldrich), Aurkb (alias AIM-1,
catalog no. 611082; BD Biosciences), phospho-H3S10 (catalog no. 06-570;
Millipore), and GAPDH (catalog no. FL-335; Santa Cruz Biotechnology
Inc.). Luciferase assays were conducted as described previously (58). A dose
dependency for cyclin D1 was obtained using 50, 100, or 150 ng of plasmid
DNA and 200 ng of reporter.
ChIP assay. ChIP material was prepared in accordance with the Magna ChIP
(Millipore) manufacturer’s guidelines. Briefly, 3-cm × 10-cm plates of actively
growing late-passage MEFs (Ccnd1–/– MSCV-IRESD1) were fixed for 10 minutes with 37% paraformaldehyde (final concentration, 1%). Unreacted formaldehyde was quenched with 1 ml of 10× glycine. The 3 plates were washed
twice with ice-cold PBS, and the pellets were harvested in 1 ml PBS with
protease inhibitor cocktail and pooled together in a 15-ml tube in order to
obtain 1.5 × 106 cells. DNA fragmentation of the pellets was achieved by sonication, 35 cycles of 20 seconds each at maximum speed using OMNI-Ruptor
4000 (OMNI International Inc). IP was performed with 10 μg FLAG-tagged
M2 antibody (Sigma-Aldrich) and equivalent amount of mouse IgG as negative control. Washes and elution of the IP DNA were performed according to
the Magna ChIP protocol (Millipore). PCR primers were designed based on
the peak interval sequence associated with cyclin D1 (Supplemental Figure 5),
and the PCR products were visualized by agarose gel electrophoresis.
PI staining. 1 × 106 randomly cycling cells were washed in PBS and fixed
overnight in 70% ethanol. RNase A (10 mg/ml) was treated for 30 minutes
at room temperature, washed, and stained with PI (20 μg/ml). PI staining
was measured using a FACSCalibur flow cytometer (BD Biosciences).
Real-time PCR. RNA quantitation was conducted in an Agilent 2100
bioanalyzer (Agilent Technologies), using Power SYBR Green (AB Biosciences) according to the manufacturer’s guidelines. Equal quantities of
RNA were used for the reverse transcription reactions. Primers (Supplemental Figure 5) for all the genes were designed using GenScript’s bioinformatics tools (GenScript).
SKY. SKY was carried out as described previously (59). Briefly, fluorescence color images of chromosomes stained by rhodamine, Texas Red, Cy5,
FITC, and Cy5.5 were captured under a Nikon microscope equipped with
a spectral cube and Interferometer module. SKY View software (version
1.62) was used to analyze chromosomal number and structural alterations
of chromosomes, including simple balanced translocations, unbalanced
translocations (i.e., NRTs), deletions, and duplications. At least 20 metaphases were analyzed per sample.
Microarray analysis. Affymetrix Expression Console 1.1 or the R statistic console with limma package was used to compute Robust Multichip
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Average (RMA) expression values for the Mouse Gene 1.0 ST microarrays
and Mouse 430A 2.0 microarrays. Microarray data have been deposited in
GEO (accession no. GSE35076; http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE35076). The core set of probe set clusters was used with
annotation version na30, dated December 2009. The dataset was imported into Matlab version R2010b (The Mathworks), and 1-way ANOVA was
used to evaluate the significance of differential expression between biological conditions. Genes with a differential expression P value of 0.01
or less and an absolute fold change of 1.25 or more were clustered and
visualized using a clustergram heatmap.
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Omnibus (http://www.ncbi.nlm.nih.gov/geo/; ref. 60) and ArrayExpress
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Immunofluorescence and confocal analysis. Immunofluorescence was performed as previously described by Silkworth et al. (62).
Statistics. To determine the number of ChIP-Seq peaks, a MACs algorithm was used (4.35% false discovery rate). Analysis of TF enrichment
within the interval sequences produced by the ChIP-Seq data was computed using a permutation test. Enrichment for high CIN scoring genes
between 2 sets was compared using Wilcoxon matched-pairs test. KaplanMeier plots were compared by log-rank test. Correlation between cyclin D1
expression and CIN was evaluated using χ2 test. For comparison between
2 independent groups, 2-tailed Student’s t test was used. A P value less
than 0.05 was considered significant.
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